Vontobel Holding’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$187K Hold
13,356
﹤0.01% 1048
2025
Q1
$209K Buy
+13,356
New +$209K ﹤0.01% 1006
2024
Q2
Sell
-21,000
Closed -$208K 1078
2024
Q1
$208K Hold
21,000
﹤0.01% 994
2023
Q4
$67.8K Sell
21,000
-28,191
-57% -$91.1K ﹤0.01% 1060
2023
Q3
$261K Buy
49,191
+21,125
+75% +$112K ﹤0.01% 936
2023
Q2
$267K Buy
28,066
+5,312
+23% +$50.6K ﹤0.01% 943
2023
Q1
$250K Buy
22,754
+2,371
+12% +$26.1K ﹤0.01% 932
2022
Q4
$287K Buy
20,383
+9,867
+94% +$139K ﹤0.01% 899
2022
Q3
$201K Buy
+10,516
New +$201K ﹤0.01% 950